ضعف (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "ضعف" in Arabic language version.

refsWebsite
Global rank Arabic rank
2nd place
5th place
1st place
1st place
4th place
6th place
6th place
3rd place
7th place
23rd place
3,257th place
7,230th place
5th place
4th place
447th place
393rd place
43rd place
2nd place

ama-assn.org

archinte.ama-assn.org

archive.org

  • Marx، John (2010). Rosen's Emergency Medicine: Concepts and Clinical Practice (ط. 7th). Philadelphia, PA: Mosby/Elsevier. ص. Chapter 11. ISBN:978-0-323-05472-0.
  • Ropper, Allan H.؛ Samuels, Martin A. (2009). Adams and Victor's Principles of Neurology, Ninth Edition. McGraw-Hill. ISBN:978-0071499927.

doi.org

fda.gov

  • Loris McVittie (12 يونيو 2008). "Information from CDC and FDA on the Safety of Gardasil Vaccine". Office of Vaccines Research and Review at the US FDA. مؤرشف من الأصل في 2008-10-04. اطلع عليه بتاريخ 2008-07-21. We have approved your supplement to your biologics license application  [لغات أخرى]‏ (BLA) for Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant (GARDASIL), to include arthralgia, myalgia, asthenia, fatigue, and malaise in the Adverse Reactions section of the package insert to reflect reports received during post-marketing surveillance, to include corresponding changes to the patient package insert, and to include additional minor editorial changes to the package insert.

nih.gov

pubmed.ncbi.nlm.nih.gov

nytimes.com

web.archive.org

wikidata.org

  • Loris McVittie (12 يونيو 2008). "Information from CDC and FDA on the Safety of Gardasil Vaccine". Office of Vaccines Research and Review at the US FDA. مؤرشف من الأصل في 2008-10-04. اطلع عليه بتاريخ 2008-07-21. We have approved your supplement to your biologics license application  [لغات أخرى]‏ (BLA) for Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant (GARDASIL), to include arthralgia, myalgia, asthenia, fatigue, and malaise in the Adverse Reactions section of the package insert to reflect reports received during post-marketing surveillance, to include corresponding changes to the patient package insert, and to include additional minor editorial changes to the package insert.

worldcat.org